Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.17/Share
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.17), versus ($0.14) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.17), versus ($0.14) reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.